Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing NMDAE plus AIFA with placebo for people with Schizophrenia. Participants receive NMDAE plus AIFA or placebo and complete study visits and assessments.
This study is looking at whether questionnaires and follow-up can help people with Schizophrenia Disorder, schizoaffective disorder, or Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with Clinical High Risk, Early Psychosis, or First Episode Psychosis. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at care and outcomes for people with Schizophrenia Negative Type. Taking part may give some people access to hDFSCs-Exo, but direct benefit is not guaranteed.
This study is looking at assess the efficacy, safety, and tolerability of GXV813 in the treatment of an acute episode of schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at care and outcomes for people with Psychosis of Childhood Borderline or psychosis. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether psychoeducation can help people with psychosis. Participants receive Peer-facilitated, Recovery-based Self-illness-management programme or usual care and complete study visits and assessments.
This study is looking at whether psychoeducation can help people with Early Psychosis or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at investigate neural markers in the cerebellar-cortical circuitry that predict treatment response to antipsychotics in first-episode psychosis for people with Psychosis or Acute. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether MDMA 40mg can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with Eating Disorders, mood conditions in Children and Adolescents, psychosis, or QTc Intervals Changes to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Mental Health, Oral Health Care, or Psychosis. Participants receive advice and support from a mental health professional about oral health and daily oral hygiene.
This study is looking at evaluate the efficacy and safety of TIS targeting the hippocampus in ameliorating cognitive impairment associated with schizophrenia (CIAS). Participants take part in temporal interference stimulation and complete follow-up assessments.
This study is looking at investigate how atorvastatin affects glucose metabolism in schizophrenia patients and assess whether metformin can help improve these metabolic issues. Participants receive Atorvastatin or placebo and complete study visits and assessments.
This study is looking at evaluate the efficacy and safety of KarXT in acutely psychotic Japanese adult participants with schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at examine the dual effects of cannabis consumption on both positive and negative symptoms of schizophrenia, across laboratory and real-world contexts. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Xanomeline and Trospium Chloride Capsules can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether a digital support tool can help people with psychosis or Schizophrenia Spectrum Disorders. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia. Taking part may give some people access to Xanomeline/trospium chloride, but direct benefit is not guaranteed.
This observational study is following people with Attention Deficit Hyperactivity Disorder, Schizophrenia, or Attention Deficit Disorder With Hyperactivity to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether a digital support tool can help people with Paranoia or psychosis. Participants take part in a digital support tool and complete follow-up assessments.